Spero Therapeutics, Inc. (SPRO)

1.23 +0.02 (+1.23%) USD  |  NASDAQ  |  Aug 25, 16:00
1.225 0.00 (0.00%) After-Hours: 19:59
More

Spero Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for SPRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
November 17, 2025 --
August 14, 2025 --
June 10, 2025 --
May 19, 2025 --
April 02, 2025 --
February 21, 2025 --
January 03, 2025 --
December 02, 2024 --
November 18, 2024 --
November 15, 2024 --
November 04, 2024 --
August 06, 2024 --
August 05, 2024 --
May 16, 2024 --
May 15, 2024 --
Date Value
April 04, 2024 --
March 18, 2024 --
March 14, 2024 --
March 13, 2024 --
February 23, 2024 --
January 06, 2024 --
November 17, 2023 --
August 14, 2023 --
August 11, 2023 --
August 10, 2023 --
May 15, 2023 --
April 10, 2023 --
March 31, 2023 --
March 30, 2023 --
February 24, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Inovio Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Kura Oncology, Inc. Upgrade
Legend Biotech Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade